Lead, WW Business Development S&E at Pfizer
Accomplished Business Development professional with broad scientific and business experience in the pharmaceutical industry. Solid track-record of leading business development activities including full technical due diligence in the areas of Oncology and Autoimmune disease for a diverse number of transactions in the whole spectrum of deal types including product licensing of clinical and preclinical candidates, M&A, technology transfers and commercial/clinical partnerships. Solid scientific background in the Oncology and Immunology/Inflammation areas. Excellent interpersonal skills and well-developed external networks with Academia, US and international pharmaceutical and biotechnology companies, and major Venture Capital and Investment Bank firms.
Ask me about
Feb 2019 - Present
Lead, Worldwide Business Development
Search & Evaluation, Oncology
Nov 2013 - Jan 2018
Senior Director of Business Development, Oncology
Responsible for BD activities in support of the Global Oncology Business Unit, including full due diligence activities, updates to senior management about competitive oncology deals, company pipeline assessments, and chairmanship of the Oncology Evaluation Team. Member of the Oncology Therapeutic Area Team. Solid track-record in a diverse number of transactions in the whole spectrum of deal types including M&A, product licensing of clinical and preclinical candidates, technology transfers and commercial/clinical partnerships, across all geographies.
Sep 2007 - Oct 2013
Director of Business Development, International BD
International Business Development. WWBD
2001 - 2007
Bristol-Myers Squibb Company
Director Of Business Development; Immunology & Inflammation
Business Development: 2001-2007 (Immunology - Autoimmune Disease; Virology) Oncology Drug Discovery: 1992-2000
Sep 1992 - 2001
Sr Research Investigator
Oncology drug discovery.